Arrowstreet Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-358,877
| Closed | -$59.3M | – | 2028 |
|
|
2021
Q2 | $59.3M | Buy |
358,877
+354,477
| +8,056% | +$59.2M | 0.07% | 298 |
|
|
2021
Q1 | $675K | Buy |
+4,400
| New | +$598K | ﹤0.01% | 1923 |
|
|
2020
Q3 | – | Sell |
-4,400
| Closed | -$428K | – | 2622 |
|
|
2020
Q2 | $428K | Buy |
+4,400
| New | +$409K | ﹤0.01% | 2007 |
|
|
2019
Q2 | – | Sell |
-31,100
| Closed | -$3.43M | – | 1847 |
|
|
2019
Q1 | $3.43M | Buy |
+31,100
| New | +$3.25M | 0.01% | 922 |
|
|
2017
Q4 | – | Sell |
-161,300
| Closed | -$12.3M | – | 1439 |
|
|
2017
Q3 | $12.3M | Buy |
161,300
+61,700
| +62% | +$4.66M | 0.03% | 345 |
|
|
2017
Q2 | $7.47M | Buy |
99,600
+61,400
| +161% | +$4.26M | 0.02% | 410 |
|
|
2017
Q1 | $2.49M | Buy |
+38,200
| New | +$2.25M | 0.01% | 751 |
|
|
2016
Q2 | – | Sell |
-17,000
| Closed | -$727K | – | 1573 |
|
|
2016
Q1 | $727K | Sell |
17,000
-75,138
| -82% | -$3.17M | ﹤0.01% | 1047 |
|
|
2015
Q4 | $4.17M | Buy |
92,138
+66,800
| +264% | +$2.81M | 0.02% | 602 |
|
|
2015
Q3 | $984K | Buy |
+25,338
| New | +$1.01M | ﹤0.01% | 930 |
|
Other funds holding PRAH
Arrowstreet Capital's PRAH Position: Q3 2021 in Review
Arrowstreet Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 358,877 shares — an estimated $59.3M sold.
Arrowstreet Capital first reported a position in PRAH in Q3 2015 and held it in 10 quarters. The position peaked at $59.3M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Arrowstreet Capital reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Arrowstreet Capital sold 358,877 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $59.3M.
- Arrowstreet Capital first reported a position in PRA Health Sciences, Inc. in Q3 2015 and held it in 10 quarters.
- Arrowstreet Capital's PRA Health Sciences, Inc. position peaked at $59.3M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Arrowstreet Capital's 13F filing for Q3 2021, filed 12 Nov 2021.